Denico Autry will miss the opening portion of the 2024 campaign. The Texans defensive end released a statement confirming he has received a six-game suspension for violating the league’s PED policy. 
Autry’s statement indicates he inadvertently ingested a banned substance while taking a prescription medication. The 34-year-old does not have a history of using performance-enhancing drugs, but this ban will keep him sidelined for the start of his Texans career. Autry will not appeal the suspension.
The former UDFA began his career with the Raiders, logging 18 starts during his four seasons with the team. Autry then kicked off his tour of the AFC South with a three-year Colts stint. In Indianapolis, he served as a full-time starter and racked up 20 sacks. From 2021-23, he played for the Titans and remained an integral member of the team’s pass rush.
Autry recorded 9.0, 8.0 and 11.5 sacks during his Tennessee campaigns before landing in Houston. The Mississippi State product signed a two-year Texans deal this offseason, and in doing so provided the team with another established producer off the edge. Houston’s offseason included the free agent departure of Jonathan Greenard, but he was replaced in the starting lineup by Danielle Hunter.
The latter will pair with 2023 third overall pick Will Anderson in anchoring Houston’s pass rush. Autry was expected to play a large role in that regard as well, but his season debut will now be delayed. The former UDFA will forfeit $1.5MM in salary, $500K in lost signing bonus compensation along with $177K in weekly roster bonuses, as detailed by Spotrac. In addition, Autry’s remaining 2024 salary ($3MM) will no longer be guaranteed.
The Texans also have the likes of Derek Barnett, Jerry Hughes and Dylan Horton along the edge. During the first six games of the season in particular, they will be counted on to step up. Autry will first be eligible to make his season debut in Week 7 against the Packers.